Rural-urban, sex variations, and time trend of primary liver cancer incidence in China, 1988-2005

European Journal of Cancer Prevention

Volumn 22, Issue 5, 2013, Pages 448-454

  Gao, Jing ^a,b,c   Xie, Li ^a,b,c   Chen, Wan Qing ^d   Zhang, Si Wei ^d   Wu, Qi Jun ^b,c   Yang, Yang ^b,c   Yang, Wan Shui ^b,c   Tan, Yu Ting ^b,c   Xiang, Yong Bing ^b,c  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

China; Epidemiology; Incidence; Liver cancer; Rural urban difference; Sex difference; Time trend

Indexed keywords

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CHINA; FEMALE; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RURAL AREA; SEX DIFFERENCE; SEX RATIO; URBAN AREA;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LIVER NEOPLASMS; MALE; MIDDLE AGED; REGISTRIES; RURAL POPULATION; SEX CHARACTERISTICS; TIME FACTORS; URBAN POPULATION; YOUNG ADULT;

EID: 84882266888     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32835de82a     Document Type: Article

References (33)

1. Bosch FX, Ribes J, Clé ries R, Díaz M (2005). Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9:191-211
2. Brechot C, Jaffredo F, Lagorce D, Gerken G, Bü schenfelde KM, Papakonstontinou A, et al. (1998). Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: Results of a European concerted action. J Hepatol 29:173-183
3. Chen JG (2001). Evaluation of research and control on liver cancer in Qidong in 15 years. Bull Chin Cancer 10:3-7
4. Chen TY, Zhu YY (2008). Analysis of incidence trends and prospective of hepatocellular carcinoma in China. Tumor 28:908-910
5. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. (2007). Cancer incidence in five continents, volume IX IARC scientific publication No. 160. Lyon, France: International Agency for Research on Cancer (IARC) Press
6. El-Serag HB (2002). Hepatocellular carcinoma: An epidemiologic view. J Clin Gastroenterol 35:S72-S78
7. Felay J (2006). The IARCcrgTools program. Lyon: IACR 2006; Available at: Http:// www.iacr.com.fr/iarccrgtools.htm/.
8. Felay J, Burkhard C, Whelan S, Parkin DM (2005). Check and conversion programs for cancer registries. IARC Technical Report No. 42. Lyon: IARC
9. Feng H, Cheng AS, Tsang DP, Li MS, Go MY, Cheung YS, et al. (2011). Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives b-catenin/T cell factor-dependent hepatocarcinogenesis. J Clin Invest 121:3159-3175
10. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010). GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC CancerBase No. 10. Lyon, France: IARC 2010; Available at: Http://globocan.iarc.fr/.
11. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, et al. (2000). The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355:887-891
12. Gao S, Yang WS, Bray F, Va P, ZhangW, Gao J, Xiang YB (2012). Declining rates of hepatocellular carcinoma in urban Shanghai: Incidence trends in 1976-2005. Eur J Epidemiol 27:39-46
13. Huang ZS, Mo ZC, Liang RX, Huang FW, Wei ZL (1992). A preliminary investigation on drinking water improvement for the prevention of hepatic cancer. Cancer 11:372-374
14. Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000). Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335-351
15. Li LD, Rao KQ (2000). The cancer incidence and mortality statistics of 11 cancer registries in China, 1988-1992. Bull Chin Cancer 9:435-447
16. Li Z, Tuteja G, Schug J, Kaestner KH (2012). Foxa1 and foxa2 are essential for sexual dimorphism in liver cancer. Cell 148:72-83
17. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. (2009). Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 27:6550-6557
18. Liang XF, Chen YS, Wang XJ, He X, Chen LJ, Wang J, et al. (2005). A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old. Chin J Epidemiol 26:655-658
19. Liu CB, Xu ZY, Cao HL, Sun YD, Chen DB, Jing Q (1991). Sero-epidemiology of HBV infection in four provinces in China. Chin J Virol 7:8-14
20. Llovet JM, Burroughs A, Bruix J (2003). Hepatocellular carcinoma. Lancet 362:1907-1917
21. National Cancer Registration Center (2004). Guideline for Chinese cancer registration. Beijing: Peking Union Medical College Press
22. Naugler WE, Sakurai T, Kim S, Maeda S, Kim KH, Elsharkawy AM, et al. (2007). Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317:121-124
23. Parkin DM, Chen VW, Ferlay J, Galceran J, Strorm HH, Whelan SL (1994). Comparability and quality control in cancer registration. IARC Technical Report No. 19. Lyon: IARC
24. Schü tze M, Boeing H, Pischon T, Rehm J, Kehoe T, Gmel G, et al. (2011). Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. Br Med J 342:d1584
25. Tanaka H, Hiyama T, Okubo Y, Kitada A, Fujimoto I (1994). Primary liver cancer incidence rates related to hepatitis C-Virus infection: A correlational study in Osaka, Japan. Cancer Causes Control 5:61-65
26. Tang ZY (2001). Recent advances in the studies of hepatocellular carcinoma. China Cancer 10:37-40
27. Williams I (1999). Epidemiology of hepatitis C in the United States. Am J Med 107 (6B):2-9
28. Xia GL, Liu CB, Cao HL, Bi SL, Zhan MY, Su CA, et al. (1996). Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992. Int Hepatol Commun 5: 62-73
29. Xiang YB, Zhang W, Gao LF, Liu ZW, Xu WH, Liu EJ, et al. (2004). Methods for time trend analysis of cancer incidence rates. Chin J Epidemiol 25: 173-177
30. Yang WS, Va P, Bray F, Gao S, Gao J, Li HL, Xiang YB (2011). The role of preexisting diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: A meta-Analysis of prospective cohort studies. PLoS One 6:e27326
31. Yeh SH, Chen PJ (2010). Gender disparity of hepatocellular carcinoma: The roles of sex hormones. Oncology 78:172-179
32. Zhang SW, Lei ZL, Li GL, Zhou XN, Zhao P, ChenWQ (2010). A report of cancer incidence and mortality from 34 cancer registries in China, 2006. China Cancer 19:356-365
33. Zheng Y,Wu CX, Bao PP, Gu K,Wang CF, Peng P, et al. (2009). A study on the morphological verification percentage of cancer cases collected by cancer registry in Shanghai: A current, retrospective and comparative exploration. J Diagn Concepts Pract 8:281-286